- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
NeoGenomics is a diagnostics & research business based in the US. NeoGenomics shares (NEO) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $16.41 – a decrease of 7.45% over the previous week. NeoGenomics employs 2,100 staff and has a trailing 12-month revenue of around $644.1 million.
What's in this guide?
Our top picks for where to buy NeoGenomics stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy NeoGenomics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – NEO. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy NeoGenomics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
NeoGenomics stock price (NASDAQ: NEO)
Use our graph to track the performance of NEO stocks over time.NeoGenomics shares at a glance
Information last updated 2024-12-18.
| Latest market close | $16.41 |
|---|---|
| 52-week range | $12.77 - $21.22 |
| 50-day moving average | $15.47 |
| 200-day moving average | $15.07 |
| Wall St. target price | $21.08 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.61 |
Is it a good time to buy NeoGenomics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
NeoGenomics price performance over time
Historical closes compared with the close of $16.4 from 2024-12-19
| 1 week (2024-12-13) | -7.50% |
|---|---|
| 1 month (2024-11-21) | 6.56% |
| 3 months (2024-09-20) | 0.74% |
| 6 months (2024-06-21) | 24.53% |
| 1 year (2023-12-21) | -20.19% |
|---|---|
| 2 years (2022-12-21) | 69.25% |
| 3 years (2021-12-21) | 34.81 |
| 5 years (2019-12-20) | 28.59 |
Is NeoGenomics stock undervalued or overvalued?
Valuing NeoGenomics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of NeoGenomics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
NeoGenomics's PEG ratio
NeoGenomics's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.02. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into NeoGenomics's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
NeoGenomics financials
| Revenue TTM | $644.1 million |
|---|---|
| Gross profit TTM | $187.9 million |
| Return on assets TTM | -2.76% |
| Return on equity TTM | -8.38% |
| Profit margin | -12.07% |
| Book value | $7.09 |
| Market Capitalization | $2.1 billion |
TTM: trailing 12 months
NeoGenomics share dividends
We're not expecting NeoGenomics to pay a dividend over the next 12 months.
Have NeoGenomics's shares ever split?
NeoGenomics's shares were split on a 1:100 basis on 15 April 2003 . So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NeoGenomics shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for NeoGenomics shares which in turn could have impacted NeoGenomics's share price.
NeoGenomics share price volatility
Over the last 12 months, NeoGenomics's shares have ranged in value from as little as $12.77 up to $21.22. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NeoGenomics's is 1.183. This would suggest that NeoGenomics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
NeoGenomics overview
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc.
Frequently asked questions
What percentage of NeoGenomics is owned by insiders or institutions?Currently 1.211% of NeoGenomics shares are held by insiders and 99.792% by institutions. How many people work for NeoGenomics?
Latest data suggests 2,100 work at NeoGenomics. When does the fiscal year end for NeoGenomics?
NeoGenomics's fiscal year ends in December. Where is NeoGenomics based?
NeoGenomics's address is: 9490 NeoGenomics Way, Fort Myers, FL, United States, 33912 What is NeoGenomics's ISIN number?
NeoGenomics's international securities identification number is: US64049M2098 What is NeoGenomics's CUSIP number?
NeoGenomics's Committee on Uniform Securities Identification Procedures number is: 64049M209
More resources on Finder
More guides on Finder
-
CashUSA: Fast But Flawed Loan Connection Up to $10K
A review of CashUSA, a loan connection service that may match you with lenders offering loans up to $10,000.
-
How to Earn Money Playing Games
Explore different ways you could earn money playing games with GPT apps, Twitch streaming, esports competitions, and trading cards.
-
Highest Paying Online Surveys
Compare highly rated and legit survey sites for your next side hustle, how to maximize your survey earnings, and how to avoid scams.
-
How to Earn Money Through User Testing
Learn how to become user tester, how much you can earn, top platforms for user testing, and how to avoid scams.
-
How to Earn Money Through Surveys
Learn how to earn money through trusted online surveys, including top platforms, practical tips, and some red flags to watch out for.
-
Online Surveys for Money
Earning extra cash can be as simple as sharing your thoughts. In this guide, we’ll walk you through some of the most trusted survey sites and show you how to get started right away.
-
Cash Advance Loans by Amount
Cash Advance loans by amount from $100 all the way up to $1,000 USD.
-
Investing After Retirement
Bonds, treasury securities, blue chip stocks, ETFs, REITs, CDs and annuities are some of the best investments for retirees.
-
Alternatives to GoHenry (Now Acorns Early)
GoHenry is now Acorns Early. If you’re looking for a GoHenry alternative, try Greenlight, Step, Current, Modak Makers or Chase First.
-
Apps Like Self
Top apps like Self that build credit include Kikoff, Grow Credit, Chime Secured Credit Builder Card, Credit Strong and Cleo.
Ask a question